The rise of Viagra initially drove a boom for pharma, but recent changes present a murky scenario for investors. Off-patent competitors are reducing profits, and continued litigation add more risk to the situation. https://mohamadpvay917999.tinyblogging.com/viagra-and-pharma-a-precarious-play-85339150